Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Research Tools
Calendars
Economic Indicators
Calculators
Education
About Us
Working with TipRanks
Follow Us
Dale Conaway Insider Profile
4 Followers
Dale Conaway, Director at Nanomix, holds 936.12K shares in Bioxytran (Ticker: BIXT), holds 7.10K shares in Nanomix (Ticker: NNMX), holds 22.81K shares in Galectin Therapeutics (Ticker: GALT).
Dale Conaway has not reported sufficient informative transactions and therefore cannot be ranked.
Time Frame
Compare to
Insider Holdings
Insider Roles
Roles that Dale Conaway holds in companies
Most Profitable Insider Trade
The most profitable trade made by Dale Conaway
Dale Conaway's Trading History
Nanomix
Jun 08, 2015
Director
Informative Buy
600.00
$106.50
Bioxytran
Apr 19, 2024
Director
Uninformative Buy
9.86K
$112.33K
Galectin Therapeutics
―
Director
―
$78.68K
List of latest transactions for each holding click on a transaction to see Dale Conaway's performance on stock
You May Also Like
Dale Conaway insider profile FAQ
What is the percentage of profitable transactions made by Dale Conaway?
The percentage of profitable transactions made by Dale Conaway is ―.
What is the average return per transaction made by Dale Conaway?
The average return per transaction made by Dale Conaway is ―.
What stocks does Dale Conaway hold?
Dale Conaway holds: NNMX, BIXT, GALT stocks.
What was Dale Conaway’s latest transaction?
Dale Conaway latest transaction was an Uninformative Buy of $9.86K.
What was Dale Conaway's most profitable transaction?
Dale Conaway’s most profitable transaction was an Informative Buy of NNMX stock on June 8, 2015. The return on the trade was -74.10%.
What is Dale Conaway's role in Nanomix?
Dale Conaway's role in Nanomix is Director.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.